Annual Total Long Term Liabilities
$57.04 M
-$4.80 M-7.77%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual total long term liabilities is $57.04 million, with the most recent change of -$4.80 million (-7.77%) on December 31, 2022.
- During the last 3 years, EVLO annual total long term liabilities has risen by +$36.06 million (+171.87%).
- EVLO annual total long term liabilities is now -7.77% below its all-time high of $61.84 million, reached on December 31, 2021.
Performance
EVLO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$7.57 M
-$3.83 M-33.59%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly total long term liabilities is $7.57 million, with the most recent change of -$3.83 million (-33.59%) on September 30, 2023.
- Over the past year, EVLO quarterly long term liabilities has dropped by -$42.51 million (-84.88%).
- EVLO quarterly long term liabilities is now -88.01% below its all-time high of $63.17 million, reached on June 30, 2021.
Performance
EVLO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
EVLO Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -7.8% | -84.9% |
3 y3 years | +171.9% | -81.5% |
5 y5 years | +419.9% | -50.9% |
EVLO Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -7.8% | at low | -87.8% | at low |
5 y | 5-year | -7.8% | +171.9% | -88.0% | at low |
alltime | all time | -7.8% | +428.3% | -88.0% | at low |
Evelo Biosciences Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $7.57 M(-33.6%) |
Jun 2023 | - | $11.40 M(-5.8%) |
Mar 2023 | - | $12.11 M(-78.8%) |
Dec 2022 | $57.04 M(-7.8%) | $57.04 M(+13.9%) |
Sep 2022 | - | $50.09 M(-8.6%) |
Jun 2022 | - | $54.81 M(-7.8%) |
Mar 2022 | - | $59.45 M(-3.9%) |
Dec 2021 | $61.84 M(+53.4%) | $61.84 M(-1.3%) |
Sep 2021 | - | $62.66 M(-0.8%) |
Jun 2021 | - | $63.17 M(+35.9%) |
Mar 2021 | - | $46.48 M(+15.3%) |
Dec 2020 | $40.32 M | $40.32 M(-1.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | $40.86 M(+31.4%) |
Jun 2020 | - | $31.09 M(-0.8%) |
Mar 2020 | - | $31.34 M(+49.4%) |
Dec 2019 | $20.98 M(+53.3%) | $20.98 M(+0.3%) |
Sep 2019 | - | $20.92 M(+28.9%) |
Jun 2019 | - | $16.23 M(+37.1%) |
Mar 2019 | - | $11.84 M(-13.5%) |
Dec 2018 | $13.68 M(+24.7%) | $13.68 M(-11.3%) |
Sep 2018 | - | $15.43 M(-1.8%) |
Jun 2018 | - | $15.72 M(-4.4%) |
Mar 2018 | - | $16.44 M(+49.9%) |
Dec 2017 | $10.97 M(+1.6%) | $10.97 M |
Dec 2016 | $10.80 M | - |
FAQ
- What is Evelo Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Evelo Biosciences?
- What is Evelo Biosciences annual total long term liabilities year-on-year change?
- What is Evelo Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Evelo Biosciences?
- What is Evelo Biosciences quarterly long term liabilities year-on-year change?
What is Evelo Biosciences annual total long term liabilities?
The current annual total long term liabilities of EVLO is $57.04 M
What is the all time high annual total long term liabilities for Evelo Biosciences?
Evelo Biosciences all-time high annual total long term liabilities is $61.84 M
What is Evelo Biosciences annual total long term liabilities year-on-year change?
Over the past year, EVLO annual total long term liabilities has changed by -$4.80 M (-7.77%)
What is Evelo Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of EVLO is $7.57 M
What is the all time high quarterly long term liabilities for Evelo Biosciences?
Evelo Biosciences all-time high quarterly total long term liabilities is $63.17 M
What is Evelo Biosciences quarterly long term liabilities year-on-year change?
Over the past year, EVLO quarterly total long term liabilities has changed by -$42.51 M (-84.88%)